UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study

Blood, 2019-02, Vol.133 (6), p.540-549

2019

Volltextzugriff (PDF)

Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature

Human pathology, 2014-11, Vol.45 (11), p.2183-2191

2014

Volltextzugriff (PDF)

A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Acta haematologica, 2020-06, Vol.143 (3), p.244-249

2020

Volltextzugriff (PDF)

One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab

European journal of haematology, 2021-03, Vol.106 (3), p.389-397

2021

Volltextzugriff (PDF)

An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians

Korean Journal of Family Medicine, 2015, 36(5), , pp.197-202

2015

Volltextzugriff (PDF)

Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia

Case reports in oncology, 2018-12, Vol.11 (3), p.880-882

2018

Volltextzugriff (PDF)

PB2554: DESIGN OF A PHASE 1B OPEN‐LABEL STUDY TO ASSESS THE SAFETY, EFFICACY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF POVETACICEPT (ALPN‐303) IN SUBJECTS WITH AUTOIMMUNE CYTOPENIAS (RUBY‐4)

HemaSphere, 2023-08, Vol.7 (S3), p.e691820b-n/a

2023

Volltextzugriff (PDF)

Autoimmune Myelofibrosis: Clinical Features, Course, and Outcome

Acta haematologica, 2017-01, Vol.138 (3), p.129-137

2017

Volltextzugriff (PDF)

Management of immune-mediated cytopenias in pregnancy

Autoimmunity reviews, 2015-09, Vol.14 (9), p.806-811

2015

Volltextzugriff (PDF)

P772: LONG‐TERM RAVULIZUMAB TREATMENT IN COMPLEMENT INHIBITOR‐EXPERIENCED PATIENTS WITH PNH PROVIDES DURABLE CONTROL OF INTRAVASCULAR HEMOLYSIS WITH LOW INCIDENCE OF MAJOR ADVERSE VASCULAR EVENTS AND DEATH

HemaSphere, 2023-08, Vol.7 (S3), p.e6327336-n/a

2023

Volltextzugriff (PDF)

P771: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS ON RAVULIZUMAB/ECULIZUMAB SHOWED HEMOGLOBIN RESPONSE SUPERIORITY WITH ADD‐ON DANICOPAN VS PLACEBO

HemaSphere, 2023-08, Vol.7 (S3), p.e777903c-n/a

2023

Volltextzugriff (PDF)

Value of routine staging imaging studies for patients with stage III breast cancer

Journal of surgical oncology, 2016-12, Vol.114 (8), p.917-921

2016

Volltextzugriff (PDF)

Further Characterization of Thromboembolic Events and Association with Platelet Count Occurring during the Avatrombopag Immune Thrombocytopenia (ITP) Clinical Development Program

Blood, 2021-11, Vol.138 (Supplement 1), p.2086-2086

2021

Volltextzugriff (PDF)

Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors

Cancer chemotherapy and pharmacology, 2014-12, Vol.74 (6), p.1227-1234

2014

Volltextzugriff (PDF)

Characterization of Thromboembolic Events Occurring during the Avatrombopag Immune Thrombocytopenia (ITP) Clinical Development Program

Blood, 2020-11, Vol.136 (Supplement 1), p.39-39

2020

Volltextzugriff (PDF)

Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study (FORWARD) of Fostamatinib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Blood, 2022-11, Vol.140 (Supplement 1), p.2438-2439

2022

Volltextzugriff (PDF)

Screening of Corticosteroid-Induced Osteoporosis in Patients with Immune Thrombocytopenia or Warm Autoimmune Hemolytic Anemia in the Outpatient Setting

Blood, 2021-11, Vol.138 (Supplement 1), p.2963-2963

2021

Volltextzugriff (PDF)

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

The New England journal of medicine, 2019-02, Vol.380 (8), p.720-728

2019

Volltextzugriff (PDF)

Improving Delays in Obtaining Lenalidomide at a Large Safety Net Hospital

Blood, 2021-11, Vol.138 (Supplement 1), p.1925-1925

2021

Volltextzugriff (PDF)

Ordering Patterns of Thrombophilia Testing and Its Appropriateness

Blood, 2021-11, Vol.138 (Supplement 1), p.1890-1890

2021

Volltextzugriff (PDF)

Thrombocytopenia: optimizing approaches in cancer patients

Oncology (Williston Park, N.Y.), 2015-04, Vol.29 (4), p.297-298

2015

Volltextzugriff (PDF)

Genetic Screens for Enhancers of brahma Reveal Functional Interactions Between the BRM Chromatin-Remodeling Complex and the Delta-Notch Signal Transduction Pathway in Drosophila

Genetics (Austin), 2005-08, Vol.170 (4), p.1761-1774

2005

Volltextzugriff (PDF)

Efficacy and Safety of Subcutaneous Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Prior Intravenous Eculizumab: 2-Year Follow-up

Blood, 2023-11, Vol.142 (Supplement 1), p.2713-2713

2023

Volltextzugriff (PDF)

A US Retrospective Observational Study of Rituximab Use in Cold Agglutinin Disease

Blood, 2023-11, Vol.142 (Supplement 1), p.3835-3835

2023

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study

Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria

Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature

A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab

An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians

Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia

PB2554: DESIGN OF A PHASE 1B OPEN‐LABEL STUDY TO ASSESS THE SAFETY, EFFICACY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF POVETACICEPT (ALPN‐303) IN SUBJECTS WITH AUTOIMMUNE CYTOPENIAS (RUBY‐4)

Autoimmune Myelofibrosis: Clinical Features, Course, and Outcome

Management of immune-mediated cytopenias in pregnancy

P772: LONG‐TERM RAVULIZUMAB TREATMENT IN COMPLEMENT INHIBITOR‐EXPERIENCED PATIENTS WITH PNH PROVIDES DURABLE CONTROL OF INTRAVASCULAR HEMOLYSIS WITH LOW INCIDENCE OF MAJOR ADVERSE VASCULAR EVENTS AND DEATH

P771: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS ON RAVULIZUMAB/ECULIZUMAB SHOWED HEMOGLOBIN RESPONSE SUPERIORITY WITH ADD‐ON DANICOPAN VS PLACEBO

Value of routine staging imaging studies for patients with stage III breast cancer

Further Characterization of Thromboembolic Events and Association with Platelet Count Occurring during the Avatrombopag Immune Thrombocytopenia (ITP) Clinical Development Program

Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors

Characterization of Thromboembolic Events Occurring during the Avatrombopag Immune Thrombocytopenia (ITP) Clinical Development Program

Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study (FORWARD) of Fostamatinib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Screening of Corticosteroid-Induced Osteoporosis in Patients with Immune Thrombocytopenia or Warm Autoimmune Hemolytic Anemia in the Outpatient Setting

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

Improving Delays in Obtaining Lenalidomide at a Large Safety Net Hospital

Ordering Patterns of Thrombophilia Testing and Its Appropriateness

Thrombocytopenia: optimizing approaches in cancer patients

Genetic Screens for Enhancers of brahma Reveal Functional Interactions Between the BRM Chromatin-Remodeling Complex and the Delta-Notch Signal Transduction Pathway in Drosophila

Efficacy and Safety of Subcutaneous Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Received Prior Intravenous Eculizumab: 2-Year Follow-up

A US Retrospective Observational Study of Rituximab Use in Cold Agglutinin Disease

Suchergebnisse filtern